Review



t philips ingenia mri scanner  (Philips Healthcare)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Philips Healthcare t philips ingenia mri scanner
    T Philips Ingenia Mri Scanner, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t+mri+scanner/pmc13276324-117-6-7?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    t philips ingenia mri scanner - by Bioz Stars, 2026-07
    86/100 stars

    Images



    Similar Products

    t philips ingenia mri scanner  (Philips Healthcare)
    86
    Philips Healthcare t philips ingenia mri scanner
    T Philips Ingenia Mri Scanner, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t+mri+scanner/pmc13276324-117-6-7?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    t philips ingenia mri scanner - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    t mri scanner  (Philips Healthcare)
    86
    Philips Healthcare t mri scanner
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    T Mri Scanner, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t+mri+scanner/pmc13276516-99-11-14?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    t mri scanner - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    t mri scanner  (Siemens Healthineers)
    86
    Siemens Healthineers t mri scanner
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    T Mri Scanner, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t+mri+scanner/pm42307080-78-7-12?v=Siemens+Healthineers
    Average 86 stars, based on 1 article reviews
    t mri scanner - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    achieva 3 t mri scanner  (Philips Healthcare)
    86
    Philips Healthcare achieva 3 t mri scanner
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Achieva 3 T Mri Scanner, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t+mri+scanner/pm42304137-57-61-66?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    achieva 3 t mri scanner - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    t trio mri scanner  (Siemens Healthineers)
    86
    Siemens Healthineers t trio mri scanner
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    T Trio Mri Scanner, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t+mri+scanner/pm42280314-143-13-17?v=Siemens+Healthineers
    Average 86 stars, based on 1 article reviews
    t trio mri scanner - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    3 0 t mri scanner  (Philips Healthcare)
    86
    Philips Healthcare 3 0 t mri scanner
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    3 0 T Mri Scanner, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t+mri+scanner/pmc13274761-211-6-12?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    3 0 t mri scanner - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    7 t mri scanner  (Siemens Healthineers)
    86
    Siemens Healthineers 7 t mri scanner
    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic <t>MRI),</t> demonstrating patient-specific changes <t>in</t> <t>T2/FLAIR</t> region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    7 T Mri Scanner, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t+mri+scanner/pm42250487-78-9-14?v=Siemens+Healthineers
    Average 86 stars, based on 1 article reviews
    7 t mri scanner - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic MRI), demonstrating patient-specific changes in T2/FLAIR region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Journal: Clinical and Translational Radiation Oncology

    Article Title: Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator

    doi: 10.1016/j.ctro.2026.101200

    Figure Lengend Snippet: Representative axial (A-C) and sagittal (C) FLAIR images from three patients at fraction 0 (F0), fraction 15 (F15), fraction 30 (F30), and 1 month post-radiotherapy (PM1; diagnostic MRI), demonstrating patient-specific changes in T2/FLAIR region-of-interest (ROI) volume (V), percentage change in V relative to F0 (V rel ), and migration distance (d migrate ). The baseline ROI at F0 is outlined in pink; ROIs at F15, F30, and PM1 are outlined in dark blue. (A) Unmethylated tumor following gross total resection (GTR), without early progression, showing decreasing ROI volume with low d migrate across timepoints. (B) Unmethylated tumor following subtotal resection (STR), with early progression, showing increasing ROI volume with increasing d migrate across timepoints. (C) Methylated tumor following STR, without early progression, showing decreasing ROI volume with large d migrate across timepoints. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: For radiotherapy planning, all patients underwent MR simulation on a 1.5 T MRI scanner (Philips Ingenia) with gadolinium-enhanced T1-weighted, T2-weighted, diffusion-weight imaging (DWI), and fluid-attenuated inversion recovery (FLAIR) volumetric sequences.

    Techniques: Diagnostic Assay, Migration, Methylation

    Longitudinal relative change in MR-Linac T2/FLAIR region of interest (ROI) volume from baseline (V rel , %) during radiotherapy by (a) fractionation regimen, (b) early progression status (progression ≤ 6 months after radiotherapy), (c) methylation status, and (d) combined early progression and methylation status. Dotted lines represent individual patients; solid lines indicate group medians. PM1 denotes the post-treatment MRI performed one month after radiotherapy and is shown separately for the 15-fraction and 30-fraction cohorts; patients treated with 15 fractions do not contribute data beyond F15.

    Journal: Clinical and Translational Radiation Oncology

    Article Title: Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator

    doi: 10.1016/j.ctro.2026.101200

    Figure Lengend Snippet: Longitudinal relative change in MR-Linac T2/FLAIR region of interest (ROI) volume from baseline (V rel , %) during radiotherapy by (a) fractionation regimen, (b) early progression status (progression ≤ 6 months after radiotherapy), (c) methylation status, and (d) combined early progression and methylation status. Dotted lines represent individual patients; solid lines indicate group medians. PM1 denotes the post-treatment MRI performed one month after radiotherapy and is shown separately for the 15-fraction and 30-fraction cohorts; patients treated with 15 fractions do not contribute data beyond F15.

    Article Snippet: For radiotherapy planning, all patients underwent MR simulation on a 1.5 T MRI scanner (Philips Ingenia) with gadolinium-enhanced T1-weighted, T2-weighted, diffusion-weight imaging (DWI), and fluid-attenuated inversion recovery (FLAIR) volumetric sequences.

    Techniques: Fractionation, Methylation

    Longitudinal migration distance (d migrate , mm) of MR-Linac T2/FLAIR region of interest (ROI) during radiotherapy by (a) fractionation regimen, (b) early progression status (progression ≤ 6 months after radiotherapy), (c) methylation status, and (d) combined early progression and methylation status. Dotted lines show individual patients; solid lines indicate group medians. PM1 denotes the post-treatment MRI performed one month after radiotherapy and is shown separately for the 15-fraction and 30-fraction cohorts; patients treated with 15 fractions do not contribute data beyond F15.

    Journal: Clinical and Translational Radiation Oncology

    Article Title: Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator

    doi: 10.1016/j.ctro.2026.101200

    Figure Lengend Snippet: Longitudinal migration distance (d migrate , mm) of MR-Linac T2/FLAIR region of interest (ROI) during radiotherapy by (a) fractionation regimen, (b) early progression status (progression ≤ 6 months after radiotherapy), (c) methylation status, and (d) combined early progression and methylation status. Dotted lines show individual patients; solid lines indicate group medians. PM1 denotes the post-treatment MRI performed one month after radiotherapy and is shown separately for the 15-fraction and 30-fraction cohorts; patients treated with 15 fractions do not contribute data beyond F15.

    Article Snippet: For radiotherapy planning, all patients underwent MR simulation on a 1.5 T MRI scanner (Philips Ingenia) with gadolinium-enhanced T1-weighted, T2-weighted, diffusion-weight imaging (DWI), and fluid-attenuated inversion recovery (FLAIR) volumetric sequences.

    Techniques: Migration, Fractionation, Methylation